Clinical trials
Completed Ovarian Neoplasms trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
123 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 10 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 8 |
| 2014 | 8 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 11 |
| 2018 | 11 |
| 2019 | 8 |
| 2020 | 1 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 123 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 11 |
| Hoffmann-La Roche | 9 |
| European Organisation for Research and Treatment of Cancer - EORTC | 8 |
| AbbVie | 5 |
| Grupo Español de Investigación en Cáncer de Ovario | 4 |
| Merck Sharp & Dohme LLC | 4 |
| pharmaand GmbH | 4 |
| Boehringer Ingelheim | 3 |
| Eli Lilly and Company | 3 |
| Hospital Universitari Vall d'Hebron Research Institute | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 123 |
| Fallopian Tube Neoplasms | 29 |
| Carcinoma, Ovarian Epithelial | 18 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Neoplasms | 13 |
| Breast Neoplasms | 12 |
| Endometrial Neoplasms | 12 |
| Triple Negative Breast Neoplasms | 11 |
| Recurrence | 10 |
| Peritoneal Neoplasms | 9 |
Trials
Showing 1 to 25 of 123. Each trial links to its page on Pharma Observatory.
23 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.